Answers are grounded in this paper and cite their sources.
The patients infected with SARS-CoV-2 have a prothrombotic state. The incidence of thromboembolic complications in patients with severe disease is much higher than in those with non-severe disease. Coagulation parameters, D-dimers, fibrinogen and platelet count are important for the identification and intervention of thromboinflammation, as early as possible. Low-molecular-weight heparin and unfractionated heparin are the anticoagulants of choice in the prevention of thrombotic complications.
No takes yet. Share an insight, caveat, or question.
Cionca et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: